Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 36, Issue 6, June 2011, Pages 427-498
 
MONOGRAPHS
 
  
 Gemcitabine Elaidate.
Cytotoxic agent, Oncolytic.
Venugopal, B., Evans, T.R.J.
Drugs Fut 2011, 36(6): 427
Summary | Full Text: HTMLPDF 
 
  
  
 ON 01910.Na.
Polo-like kinase 1 inhibitor, Oncolytic.
Taft, D.R., Dave, R., Gillum, A.M., Maniar, M.
Drugs Fut 2011, 36(6): 433
Summary | Full Text: HTMLPDF 
 
  
  
 Secukinumab.
Fully human anti-IL-17 monoclonal antibody.
Gonzalez-Gonzalez, L.A., Foster, C.S.
Drugs Fut 2011, 36(6): 441
Summary | Full Text: HTMLPDF 
 
  
  
 Velusetrag.
5-HT4 receptor agonist, Treatment of chronic constipation.
Vazquez-Roque, M., Camilleri, M.
Drugs Fut 2011, 36(6): 447
Summary | Full Text: HTMLPDF 
 
  
 
REVIEW ARTICLES
 
  
 Antiviral drug susceptibility patterns in gammaretroviridae: lessons from XMRV and related retroviruses.
Smith, R.A.
Drugs Fut 2011, 36(6): 455
Summary | Full Text: HTMLPDF 
 
  
  
 Chemokine receptor CXCR2 antagonism to prevent airways inflammation.
Donnelly, L.E. , Barnes, P.J.
Drugs Fut 2011, 36(6): 465
Summary | Full Text: HTMLPDF 
 
  
 
TARGETS TO WATCH
 
  
 Therapeutic targets for anxiety disorders.
Sorbera, L.A., Dulsat, C., Rosa, E.
Drugs Fut 2011, 36(6): 473
Summary | Full Text: HTMLPDF 
 
  
 
MEETING REPORT
 
  
 New drugs for HIV and hepatitis C virus infections: A report from CROI 2011.
Temesgen, Z.
Drugs Fut 2011, 36(6): 485
Summary | Full Text: HTMLPDF 
 
  
  
 News from the 10th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD).
Cole, P.
Drugs Fut 2011, 36(6): 491
Summary | Full Text: HTMLPDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy